|
DNAJB6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03840000001509E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.84560000000045E-05 |
| Normal-vs-Stage2 |
3.835000E-01 |
| Normal-vs-Stage3 |
3.65340000030301E-07 |
| Normal-vs-Stage4 |
2.146599999997E-05 |
| Stage1-vs-Stage2 |
2.375600E-01 |
| Stage1-vs-Stage3 |
2.963500E-02 |
| Stage1-vs-Stage4 |
2.496100E-02 |
| Stage2-vs-Stage3 |
3.127700E-02 |
| Stage2-vs-Stage4 |
2.237600E-02 |
| Stage3-vs-Stage4 |
6.024600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73650000001579E-06 |
| Normal-vs-AfricanAmerican |
8.408000E-04 |
| Normal-vs-Asian |
2.460100E-03 |
| Caucasian-vs-AfricanAmerican |
6.640000E-01 |
| Caucasian-vs-Asian |
5.642400E-01 |
| AfricanAmerican-vs-Asian |
4.155000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.961300E-03 |
| Normal-vs-Female |
7.31920000052177E-07 |
| Male-vs-Female |
3.710400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.432500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.99039999998685E-06 |
| Normal-vs-Age(61-80Yrs) |
2.350400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.475400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.254000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.037600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.186600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.438600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.890000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.795500E-03 |
| Classical-VS-Follicular |
9.860000E-01 |
| Classical-VS-Other |
6.778200E-01 |
| Classical-VS-Normal |
1.177710E-04 |
| Tall-VS-Follicular |
6.856400E-03 |
| Tall-VS-Other |
2.133600E-01 |
| Tall-VS-Normal |
3.25490000507855E-08 |
| Follicular-VS-Other |
5.993200E-01 |
| Follicular-VS-Normal |
5.838500E-03 |
| Other-VS-Normal |
7.223000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83746999999901E-05 |
| Normal-vs-N1 |
1.68425000000028E-05 |
| N0-vs-N1 |
1.437550E-01 |
|
|
